GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InnoCare Pharma Ltd (HKSE:09969) » Definitions » Forward Dividend Yield %

InnoCare Pharma (HKSE:09969) Forward Dividend Yield % : 0.00% (As of May. 11, 2024)


View and export this data going back to 2020. Start your Free Trial

What is InnoCare Pharma Forward Dividend Yield %?

As of today (2024-05-11), the Forward Annual Dividend Yield of InnoCare Pharma is 0.00%.

As of today (2024-05-11), the Trailing Annual Dividend Yield of InnoCare Pharma is 0.00%.

HKSE:09969's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.455
* Ranked among companies with meaningful Forward Dividend Yield % only.

InnoCare Pharma's Dividends per Share for the three months ended in Dec. 2023 was HK$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of InnoCare Pharma's Forward Dividend Yield %

For the Biotechnology subindustry, InnoCare Pharma's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnoCare Pharma's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InnoCare Pharma's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where InnoCare Pharma's Forward Dividend Yield % falls into.



InnoCare Pharma Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


InnoCare Pharma  (HKSE:09969) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


InnoCare Pharma Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of InnoCare Pharma's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


InnoCare Pharma (HKSE:09969) Business Description

Traded in Other Exchanges
Address
No. 8 Life Science Park Road, Building 8, Zhongguancun Life Science Park, Changping District, Beijing, CHN, 102206
InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. The company's main product pipeline includes orelabrutinib, ibrutinib, zanubrutinib, tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723, and ICP-189, among others. Its products are mainly used to treat hematological tumors, solid tumors, and autoimmune diseases. The company is also developing products for the treatment of autoimmune diseases caused by abnormal B-cell or T-cell function.

InnoCare Pharma (HKSE:09969) Headlines

No Headlines